CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $12.89 million. The enterprise value is $11.43 million.

Market Cap	12.89M
Enterprise Value	11.43M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 15.80 million shares outstanding. The number of shares has increased by 25.12% in one year.

Current Share Class	15.80M
Shares Outstanding	15.80M
Shares Change (YoY)	+25.12%
Shares Change (QoQ)	+3.08%
Owned by Insiders (%)	9.45%
Owned by Institutions (%)	34.36%
Float	10.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.61

Current Ratio	1.61
Quick Ratio	1.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.18

Financial Efficiency

Return on equity (ROE) is -399.51% and return on invested capital (ROIC) is -110.80%.

Return on Equity (ROE)	-399.51%
Return on Assets (ROA)	-81.85%
Return on Invested Capital (ROIC)	-110.80%
Return on Capital Employed (ROCE)	-674.61%
Weighted Average Cost of Capital (WACC)	12.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.03% in the last 52 weeks. The beta is 1.31, so CalciMedica's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-48.03%
50-Day Moving Average	0.71
200-Day Moving Average	2.31
Relative Strength Index (RSI)	52.38
Average Volume (20 Days)	3,364,971

Short Selling Information

The latest short interest is 276,326, so 1.75% of the outstanding shares have been sold short.

Short Interest	276,326
Short Previous Month	144,356
Short % of Shares Out	1.75%
Short % of Float	2.68%
Short Ratio (days to cover)	0.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.24M
Pretax Income	-19.54M
Net Income	-19.54M
EBITDA	-22.20M
EBIT	-22.24M
Earnings Per Share (EPS)	-$1.27

Full Income Statement

Balance Sheet

The company has $8.16 million in cash and $6.70 million in debt, giving a net cash position of $1.46 million or $0.09 per share.

Cash & Cash Equivalents	8.16M
Total Debt	6.70M
Net Cash	1.46M
Net Cash Per Share	$0.09
Equity (Book Value)	-1.10M
Book Value Per Share	-0.07
Working Capital	3.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.16 million and capital expenditures -$19,000, giving a free cash flow of -$21.18 million.

Operating Cash Flow	-21.16M
Capital Expenditures	-19,000
Depreciation & Amortization	38,000
Net Borrowing	-102,000
Free Cash Flow	-21.18M
FCF Per Share	-$1.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.12%
Shareholder Yield	-25.12%
Earnings Yield	-151.63%
FCF Yield	-164.28%

Analyst Forecast

The average price target for CalciMedica is $10.33, which is 1,166.09% higher than the current price. The consensus rating is "Buy".

Price Target	$10.33
Price Target Difference	1,166.09%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1